Table 2.
Clinicopathological characteristics of patients according to the KC
| Characteristics | Within KC (n = 35) | Beyond KC (n = 21) | p value |
|---|---|---|---|
| Age, years | 57 (22–69) | 55 (23–62) | 0.38 |
| Sex (male/female) | 29/6 | 14/7 | 0.16 |
| Etiology | 0.96 | ||
| Viral hepatitis C | 17 | 11 | |
| Viral hepatitis B | 12 | 6 | |
| Viral hepatitis C/B | 1 | 1 | |
| Others | 5 | 3 | |
| AFP, ng/mL | 51 (2–3,564) | 237 (3–212,220) | 0.28 |
| DCP, mAU/mL | 54 (2–400) | 443 (12–20,600) | 0.01 |
| Child-Pugh (A/B/C) | 15/20/0 | 9/12/0 | 1.00 |
| MELD | 11 (6–22) | 10 (4–17) | 0.40 |
| Maximum tumor size, cm | 3.4 (1–5) | 3.6 (1–26) | 0.14 |
| Tumors, n | 5 (2–10) | 12 (2–186) | 0.03 |
| Classification (well/mod./poor) | 1/26/8 | 3/13/5 | 0.26 |
| Microvascular invasion | 16 (46%) | 15 (71%) | 0.06 |
AFP, α-fetoprotein; DCP, des-gamma-carboxy prothrombin; MELD, model for end-stage liver disease.